Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Forman

Showing results (431-440 of 446) with videos related to

Pageof 45
Sort By:
Nature Medicine|June 12, 2024
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trialTanya B Dorff, M Suzette Blanchard, Lauren N Adkins, et al.
Transplantation and Cellular Therapy|March 30, 2026
Disability-Free Survival: A Novel Morbidity Endpoint for Older Adult Allogeneic Hematopoietic Cell TransplantationJorge M Ramos Perez, Haoyue Shan, Dongyun Yang, et al.
Biorxiv : the Preprint Server for Biology|July 12, 2026
Radioligand therapy in combination with CAR T cells overcomes the heterogeneous immunosuppressive prostate tumor microenvironmentJiangyue Liu, Iveta Fajnorova, Yuwei Ren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2017
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for LymphomaChristopher J Gibson, R Coleman Lindsley, Vatche Tchekmedyian, et al.
Haematologica|November 7, 2024
Venetoclax in combination with a pediatric-inspired regimen for the treatment of newly diagnosed adults with Philadelphia chromosome-negative acute lymphoblastic leukemiaIbrahim Aldoss, Jianying Zhang, Kathryn Shimamoto, et al.
Nature Medicine|March 7, 2024
Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trialChristine E Brown, Jonathan C Hibbard, Darya Alizadeh, et al.
Blood Advances|June 24, 2026
CAR T Cell Therapy as a Definitive Consolidation for Older Adults with B-ALL in First Complete RemissionIbrahim Aldoss, Lior Goldberg, Jianying Zhang, et al.
Nature Medicine|March 6, 2018
Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemiaBin Zhang, Le Xuan Truong Nguyen, Ling Li, et al.
Frontiers in Immunology|September 20, 2021
Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 TrialPolina Shindiapina, Maciej Pietrzak, Michal Seweryn, et al.
Vaccines|September 28, 2023
Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular TherapyFlavia Chiuppesi, Sandra Ortega-Francisco, Miguel-Angel Gutierrez, et al.
Pageof 45

Showing results (431-440 of 446) with videos related to

Sort By:
Pageof 45
Nature Medicine|June 12, 2024
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trialTanya B Dorff, M Suzette Blanchard, Lauren N Adkins, et al.
Transplantation and Cellular Therapy|March 30, 2026
Disability-Free Survival: A Novel Morbidity Endpoint for Older Adult Allogeneic Hematopoietic Cell TransplantationJorge M Ramos Perez, Haoyue Shan, Dongyun Yang, et al.
Biorxiv : the Preprint Server for Biology|July 12, 2026
Radioligand therapy in combination with CAR T cells overcomes the heterogeneous immunosuppressive prostate tumor microenvironmentJiangyue Liu, Iveta Fajnorova, Yuwei Ren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2017
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for LymphomaChristopher J Gibson, R Coleman Lindsley, Vatche Tchekmedyian, et al.
Haematologica|November 7, 2024
Venetoclax in combination with a pediatric-inspired regimen for the treatment of newly diagnosed adults with Philadelphia chromosome-negative acute lymphoblastic leukemiaIbrahim Aldoss, Jianying Zhang, Kathryn Shimamoto, et al.
Nature Medicine|March 7, 2024
Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trialChristine E Brown, Jonathan C Hibbard, Darya Alizadeh, et al.
Blood Advances|June 24, 2026
CAR T Cell Therapy as a Definitive Consolidation for Older Adults with B-ALL in First Complete RemissionIbrahim Aldoss, Lior Goldberg, Jianying Zhang, et al.
Nature Medicine|March 6, 2018
Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemiaBin Zhang, Le Xuan Truong Nguyen, Ling Li, et al.
Frontiers in Immunology|September 20, 2021
Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 TrialPolina Shindiapina, Maciej Pietrzak, Michal Seweryn, et al.
Vaccines|September 28, 2023
Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular TherapyFlavia Chiuppesi, Sandra Ortega-Francisco, Miguel-Angel Gutierrez, et al.
Pageof 45